Clinical Trial Update: Evaluating the Impact of 'Tertinat' on Patients with Atherosclerosis-Related Cardiovascular Diseases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the impact of Tertinat on atherosclerosis-related cardiovascular diseases; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Carotid Atherosclerosis
• Coronary Atherosclerosis

Drugs mentioned

• Tertinat

Snippet

Sponsor: Institute for Atherosclerosis Research, Russia | Conditions: Atherosclerosis, Atheroscleroses, Coronary | Phase 2 | Status: RECRUITING